Phase II study application for FB-704A in severe asthma receives approval in Taiwan April 21, 2021 No Comments
scRNA-seq and gene expression analysis of lung immune cells in a model of RA-associated lung disease April 13, 2021 No Comments
Boehringer Ingelheim starts enrolling participants in phase I study of BI-1323495 April 8, 2021 No Comments
Jiangsu Chia Tai Tianqing Pharmaceutical Group, Boision present antibodies binding TSLP March 30, 2021 No Comments
Phase IIb/III study of Zyesami for respiratory failure in critical COVID-19 meets primary endpoint March 29, 2021 No Comments